Drug Topics

JULY 6, 2023

Researchers concluded that older patients with stable MS can stop taking disease-modifying therapy because risk of relapse is so small.

98

98

Fierce Pharma

JULY 6, 2023

After becoming chairman of the powerful Senate Health, Education, Labor and Pensions Committee earlier this year, Sen. | After becoming chairman of the powerful Senate Health, Education, Labor and Pensions Committee earlier this year, Sen. Bernie Sanders, I-Vermont—a longtime opponent of Big Pharma—has become even more ubiquitous in his efforts to reduce drug prices.

145

145

Fierce Healthcare

JULY 4, 2023

The Biden administration issued a proposal Friday to cut reimbursements to home health providers by 2.2% next year, or an estimated $375 million less than 2023 payment levels. | The Biden administration issued a proposal Friday to cut reimbursements to home health providers by 2.2% next year, or an estimated $375 million less than 2023 payment levels.

122

122

Drug Topics

JULY 5, 2023

How does AI help reduce the burden on specialist dermatology services and help simplify the screening process?

180

180

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Healthcare

JULY 6, 2023

Stanford Medicine and the Department of Veterans Affairs (VA) unveiled plans Friday to collaborate on a project that will bring a new National Cancer Institute-designated joint cancer care and rese | Stanford Medicine and the VA unveiled plans on Friday to collaborate on a project that will bring a new National Cancer Institute-designated joint cancer care and research center to the VA Palo Alto campus.

Department of Veterans Affairs 111

Department of Veterans Affairs 111

PharmExec

JULY 5, 2023

Rose Blackburne, MD, MBA, vice president, global head, general medicine, PPD Clinical Research, Thermo Fisher Scientific, discusses health equity in pharma, specifically racial biases, and how the industry can address inequities in access and care going forward.

105

105

Pharmaceutical Technology

JULY 3, 2023

Pipeline developments within the obesity space have recently garnered interest following recent results published on Eli Lilly’s retatrutide.

119

119

Fierce Pharma

JULY 6, 2023

During the first earnings call Brent Saunders led since his return at Bausch + Lomb, the CEO laid out what he believes is the company’s biggest issue: underutilization of existing infrastructure. | During the first earnings call Brent Saunders led since his return at Bausch + Lomb, the CEO laid out what he believes is the company’s biggest issue: underutilization of existing infrastructure.

110

110

Pharmacy Times

JULY 3, 2023

The study also found significant evidence of outcomes disparities between minority populations and White populations.

149

149

STAT

JULY 7, 2023

Jonathan Studnek knows some people imagine that driving an ambulance at high speed with lights flashing and sirens wailing — racing through messily parted traffic to the scene of a crisis — is the best part of being an emergency medic. For him, that couldn’t be further from the truth. “If you’ve been in the industry for any length, you know innately: When you’re in the front of an ambulance and the lights are on, that’s the most dangerous situatio

Hospitals 133

Hospitals 133

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

JULY 4, 2023

Substance use disorders leave people with long-term negative mental and physical health implications and can lead to death.

130

130

Fierce Pharma

JULY 6, 2023

Less than two months into its "Pivot to Growth" strategy under a new CEO, Israeli-American generics giant Teva Pharmaceutical could be weighing a major shake-up of its key drug ingredients business | Teva is looking at strategic options for its active pharmaceutical ingredient unit, with a potential sale on the table, BNN Bloomberg and Benzinga have reported.

143

143

Pharmacy Times

JULY 6, 2023

The benefits of the survey can stretch beyond assessing the parental acceptability of mental health screenings in children and can suggest areas of optimization in providing these screenings more widely and effectively in the future.

132

132

STAT

JULY 3, 2023

When the U.S. Supreme Court released its landmark ruling overturning the use of race-conscious college admissions, LaShyra Nolen was on clinical rotation. For Nolen, a fourth-year medical student at Harvard Medical School, the news sent a chill down her spine even though she had been anticipating it. “It felt very lonely,” said Nolen, who is Black and the first in her family to get a bachelors of science degree and attend medical school.

Medical Schools 126

Medical Schools 126

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

JULY 7, 2023

Air pollution shown to increase depression symptoms in individuals with bipolar disorder, a new study published by Cambridge University Press found.

124

124

Fierce Pharma

JULY 7, 2023

As demand skyrockets for GLP-1 drugs that can trigger significant weight loss, unauthorized versions of the treatments have started to fill pharmacies. | In late May, the FDA warned of illegal knockoffs of Novo Nordisk’s Ozempic and Wegovy. And now, the Danish company has filed its second wave of lawsuits against pharmacies in the U.S. that are producing the copycats.

Compounding 130

Compounding FDA 130

Pharmacy Times

JULY 5, 2023

Pharmacists can use their knowledge and professional judgment to educate patients about when it is appropriate to take these medications and when to avoid them.

132

132

STAT

JULY 6, 2023

The STAT Diversity and Inclusion Committee is proud to present STAT’s inaugural Diversity and Inclusion Report. Here, we share the self-reported gender and racial/ethnic demographics of our staff from STAT’s inception in 2015 through 2022. This report presents an opportunity to reaffirm STAT’s commitment to becoming the most diverse media company covering the life sciences and health care.

120

120

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

JULY 4, 2023

Psychedelics and mental health: The time is now? Nicole.

117

117

Fierce Pharma

JULY 6, 2023

It’s official: Roughly half a year after the FDA granted an accelerated nod to Eisai and Biogen’s new Alzheimer’s disease med lecanemab, the companies have converted that green light into a full-fl | With a full approval in hand, Leqembi has become the first treatment shown to reduce the rate of disease progression and slow cognitive and functional decline in adults with Alzheimer’s disease under the FDA's traditional approval pathway.

FDA 116

FDA 116

Pharmacy Times

JULY 7, 2023

Diagnostic technologies are advancing quickly, which may lead to therapeutics for age-related diseases to safely reduce chronic low-grade inflammation generated by the immune system.

Immunization 123

Immunization 123

STAT

JULY 7, 2023

The recent FDA approval of Leqembi , the latest anti-amyloid drug, is undoubtedly a breakthrough for the field, providing a new way to slow the advancement of mild cognitive impairment or early-stage Alzheimer’s disease. As a practicing geriatrician who has treated Alzheimer’s patients for more than 40 years and the co-founder and chief science officer at the Alzheimer’s Drug Discovery Foundation, I have never been more optimistic about our potential to transform how we trea

FDA 119

FDA 119

Fierce Healthcare

JULY 5, 2023

“Digital health will cease to exist,” read large on the screen behind Merck Global Health Initiative Fund President Bill Taranto at the second annual HITLAB Innovators Summit in New York City. | Columbia University hosted the second annual HITLAB Innovators Summit in New York City where industry insiders trumpeted the potential for digital health interventions while warning of the dangers of unchecked tech implementation.

115

115

Fierce Pharma

JULY 6, 2023

GSK’s Cabenuva made history in 2020 as the world’s firs | GSK's long-acting Cabenuva is currently approved only as a switch therapy for patients who already have undetectable HIV levels in the blood. Trying to reach some tough populations who have difficulty adhering to existing daily oral therapies, GSK is getting creative.

111

111

Pharmacy Times

JULY 7, 2023

Expert Nikhil Palekar, MD, said that although the treatment is far from a cure, it is a vital first step toward other treatments for Alzheimer Disease.

123

123

STAT

JULY 5, 2023

WASHINGTON – Novo Nordisk spent $11 million on meals and travel for thousands of doctors last year, federal records show, as part of its push to promote Ozempic and other weight loss-inducing diabetes drugs. The pharmaceutical company bought more than 457,000 meals to educate doctors and other prescribers about its portfolio of drugs known as GLP-1 agonists, according to the newly released data from the Centers for Medicare and Medicaid Services.

Pharmaceutical Companies 116

Pharmaceutical Companies Pharmaceutical Companies 116

Fierce Healthcare

JULY 5, 2023

Hospital outpatient departments are marking up the prices for biologic medicines more than physician offices, particularly for “innovator biologics” that have clinically equivalent and lower cost a | Consistently higher markups among hospital outpatient departments hamstring potential savings payers may hope to see down the line as more biosimilars become available, warned the Employee Benefit Research Institute.

Hospitals 111

Hospitals 111

Pharmaceutical Technology

JULY 4, 2023

While drug shortages have been a major cause for concern over the past few years, medications to treat cancer are in particularly short supply.

111

111

Pharmacy Times

JULY 7, 2023

Oncology pharmacy is best learned in real time with real oncologists and real patients.

123

123

STAT

JULY 6, 2023

When then-Vice President Biden launched the Cancer Moonshot in 2016, there was reason to be optimistic. Decades of rigorous science had transformed many cancers from a death sentence to a manageable chronic disease. New treatment advances — including gene and cell therapies and immunotherapies — were showing stunning results. With support from the biopharmaceutical industry and the help of smart government policies, ending cancer was, and is, an achievable goal.

111

111

Fierce Healthcare

JULY 5, 2023

The quality bonus program (QBP) that rewards Medicare Advantage (MA) plans fails to achieve its two main goals: fairly rewarding MA insurers that actually improve quality and encouraging beneficiar | The Medicare Advantage Quality Bonus Program suffers from what some experts call the “Lake Wobegon Effect”: Too many plans are rated above average. A new Urban Institute report suggests some cures.

Insurance 111

Insurance 111

Pharmaceutical Technology

JULY 6, 2023

Lifera, Arabio and Sanofi have signed a memorandum of understanding (MOU) to bolster manufacturing of vaccines in Saudi Arabia.

Vaccines 111

Vaccines 111

Pharmacy Times

JULY 6, 2023

The safety and efficacy of long-term benzodiazepine use beyond the recommended timeframe is not well understood.

123

123